Literature DB >> 34353540

A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48.

David D Berg, Robert P Giugliano, Christian T Ruff, Minao Tang, KyungAh Im, Petr Jarolim, Howard Rutman, Elliott M Antman, Eugene Braunwald, David A Morrow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34353540      PMCID： PMC8857944          DOI： 10.1016/j.jacc.2021.06.008

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.

Authors:  David D Berg; Christian T Ruff; Petr Jarolim; Robert P Giugliano; Francesco Nordio; Hans J Lanz; Michele F Mercuri; Elliott M Antman; Eugene Braunwald; David A Morrow
Journal:  Circulation       Date:  2019-02-05       Impact factor: 29.690

Review 2.  Biomarkers for Risk Assessment in Atrial Fibrillation.

Authors:  David D Berg; Christian T Ruff; David A Morrow
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

3.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245
  3 in total
  1 in total

1.  Improving prediction of anticoagulant-related major bleeding in atrial fibrillation: The search for new biomarkers.

Authors:  David D Berg; David A Morrow
Journal:  J Thromb Haemost       Date:  2021-11       Impact factor: 5.824
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.